Christopher H Gibbons, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Autonomic Nervous System Diseases | 27 | 2023 | 269 | 7.800 |
Why?
|
Diabetic Neuropathies | 15 | 2022 | 405 | 5.480 |
Why?
|
Hypotension, Orthostatic | 19 | 2021 | 256 | 4.790 |
Why?
|
alpha-Synuclein | 14 | 2024 | 749 | 3.650 |
Why?
|
Parkinson Disease | 20 | 2024 | 2862 | 2.990 |
Why?
|
Autonomic Nervous System | 13 | 2023 | 697 | 2.670 |
Why?
|
Skin | 22 | 2024 | 4464 | 2.580 |
Why?
|
Postural Orthostatic Tachycardia Syndrome | 10 | 2022 | 51 | 2.450 |
Why?
|
Peripheral Nervous System Diseases | 12 | 2023 | 708 | 2.380 |
Why?
|
Nerve Fibers | 14 | 2024 | 708 | 2.190 |
Why?
|
Multiple System Atrophy | 8 | 2024 | 129 | 2.110 |
Why?
|
Sweating | 5 | 2019 | 154 | 1.770 |
Why?
|
Neuralgia | 6 | 2020 | 600 | 1.760 |
Why?
|
Ganglia, Autonomic | 6 | 2012 | 43 | 1.250 |
Why?
|
Biopsy | 14 | 2024 | 6768 | 1.190 |
Why?
|
Autonomic Pathways | 3 | 2020 | 31 | 1.190 |
Why?
|
Autoimmune Diseases of the Nervous System | 4 | 2011 | 75 | 1.180 |
Why?
|
Primary Dysautonomias | 3 | 2021 | 28 | 1.150 |
Why?
|
Valsalva Maneuver | 7 | 2019 | 99 | 1.090 |
Why?
|
Tilt-Table Test | 9 | 2021 | 79 | 1.090 |
Why?
|
Lewy Body Disease | 5 | 2024 | 252 | 1.060 |
Why?
|
Posture | 7 | 2021 | 953 | 1.050 |
Why?
|
Heart Rate | 12 | 2021 | 4166 | 1.010 |
Why?
|
Amyloid Neuropathies, Familial | 3 | 2024 | 150 | 1.010 |
Why?
|
Syncope | 4 | 2020 | 427 | 0.970 |
Why?
|
Polyneuropathies | 3 | 2020 | 137 | 0.970 |
Why?
|
Erythromelalgia | 2 | 2014 | 15 | 0.930 |
Why?
|
Blood Pressure | 12 | 2021 | 8453 | 0.870 |
Why?
|
Reflex | 5 | 2019 | 376 | 0.860 |
Why?
|
Sensory Receptor Cells | 4 | 2018 | 509 | 0.850 |
Why?
|
Pure Autonomic Failure | 5 | 2024 | 16 | 0.810 |
Why?
|
Sweat Glands | 4 | 2011 | 33 | 0.780 |
Why?
|
Skin Physiological Phenomena | 3 | 2018 | 188 | 0.750 |
Why?
|
Microvessels | 3 | 2020 | 572 | 0.730 |
Why?
|
REM Sleep Behavior Disorder | 1 | 2021 | 108 | 0.720 |
Why?
|
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 1 | 2020 | 33 | 0.710 |
Why?
|
Immunoglobulins, Intravenous | 2 | 2022 | 664 | 0.690 |
Why?
|
Peripheral Nerves | 3 | 2020 | 475 | 0.680 |
Why?
|
Iatrogenic Disease | 2 | 2020 | 538 | 0.650 |
Why?
|
Epidermis | 4 | 2015 | 528 | 0.630 |
Why?
|
Gastroparesis | 1 | 2020 | 136 | 0.620 |
Why?
|
Diagnostic Self Evaluation | 1 | 2020 | 225 | 0.610 |
Why?
|
Laser-Doppler Flowmetry | 3 | 2013 | 239 | 0.600 |
Why?
|
Electrochemical Techniques | 1 | 2018 | 94 | 0.590 |
Why?
|
Genetic Diseases, X-Linked | 1 | 2021 | 378 | 0.590 |
Why?
|
Galvanic Skin Response | 2 | 2018 | 348 | 0.580 |
Why?
|
Hypoglycemia | 2 | 2017 | 881 | 0.580 |
Why?
|
Dystonic Disorders | 1 | 2021 | 342 | 0.560 |
Why?
|
Diabetes Mellitus, Type 1 | 3 | 2017 | 3432 | 0.560 |
Why?
|
Sympathetic Fibers, Postganglionic | 3 | 2019 | 14 | 0.560 |
Why?
|
Baroreflex | 2 | 2018 | 148 | 0.540 |
Why?
|
Hypoglycemic Agents | 3 | 2020 | 3069 | 0.520 |
Why?
|
Central Nervous System Diseases | 1 | 2020 | 520 | 0.500 |
Why?
|
Diabetic Angiopathies | 2 | 2017 | 802 | 0.500 |
Why?
|
Humans | 106 | 2024 | 758381 | 0.480 |
Why?
|
Friends | 1 | 2015 | 150 | 0.470 |
Why?
|
Exercise Therapy | 1 | 2021 | 919 | 0.450 |
Why?
|
Diabetes Complications | 1 | 2020 | 1317 | 0.440 |
Why?
|
Pain Threshold | 2 | 2020 | 603 | 0.440 |
Why?
|
Capsaicin | 2 | 2013 | 231 | 0.440 |
Why?
|
Pain | 5 | 2022 | 5065 | 0.430 |
Why?
|
Sympathetic Nervous System | 2 | 2006 | 518 | 0.430 |
Why?
|
Autopsy | 1 | 2017 | 1003 | 0.430 |
Why?
|
Nerve Degeneration | 2 | 2023 | 748 | 0.420 |
Why?
|
Endocrinology | 3 | 2023 | 441 | 0.410 |
Why?
|
Diabetes Mellitus | 6 | 2023 | 5818 | 0.400 |
Why?
|
Autoantibodies | 5 | 2022 | 2118 | 0.400 |
Why?
|
Glucose Clamp Technique | 1 | 2012 | 263 | 0.400 |
Why?
|
Activities of Daily Living | 1 | 2021 | 2414 | 0.380 |
Why?
|
Neurophysiology | 2 | 2020 | 144 | 0.380 |
Why?
|
Sensory System Agents | 1 | 2010 | 21 | 0.370 |
Why?
|
Spinal Cord | 1 | 2019 | 1815 | 0.360 |
Why?
|
Middle Aged | 42 | 2024 | 219560 | 0.330 |
Why?
|
Blood Flow Velocity | 1 | 2013 | 1370 | 0.330 |
Why?
|
Papillomavirus Vaccines | 3 | 2020 | 497 | 0.330 |
Why?
|
Mycophenolic Acid | 2 | 2009 | 343 | 0.320 |
Why?
|
Phosphorylation | 4 | 2024 | 8297 | 0.320 |
Why?
|
Dizziness | 2 | 2020 | 257 | 0.320 |
Why?
|
Sweat | 1 | 2008 | 56 | 0.310 |
Why?
|
Insulin | 4 | 2017 | 6578 | 0.310 |
Why?
|
Diagnostic Techniques, Neurological | 1 | 2008 | 62 | 0.310 |
Why?
|
Hyperglycemia | 1 | 2017 | 1368 | 0.300 |
Why?
|
Receptors, Nicotinic | 2 | 2009 | 494 | 0.300 |
Why?
|
Hyperalgesia | 1 | 2012 | 530 | 0.300 |
Why?
|
Male | 48 | 2024 | 358742 | 0.290 |
Why?
|
Neurologic Examination | 4 | 2019 | 914 | 0.290 |
Why?
|
Plasmapheresis | 1 | 2008 | 206 | 0.290 |
Why?
|
Female | 48 | 2024 | 390316 | 0.280 |
Why?
|
Adult | 34 | 2024 | 219916 | 0.280 |
Why?
|
Electrocardiography | 2 | 2017 | 6363 | 0.270 |
Why?
|
Prednisone | 2 | 2009 | 1565 | 0.270 |
Why?
|
Caregivers | 1 | 2018 | 2224 | 0.270 |
Why?
|
Norepinephrine | 2 | 2005 | 897 | 0.270 |
Why?
|
Droxidopa | 1 | 2005 | 10 | 0.260 |
Why?
|
Pathology | 1 | 2009 | 270 | 0.260 |
Why?
|
Quality of Life | 3 | 2022 | 13286 | 0.240 |
Why?
|
Sensation Disorders | 1 | 2006 | 160 | 0.240 |
Why?
|
Stress, Physiological | 1 | 2012 | 1398 | 0.240 |
Why?
|
Diabetes Mellitus, Type 2 | 6 | 2023 | 12076 | 0.240 |
Why?
|
Autoantigens | 1 | 2009 | 877 | 0.240 |
Why?
|
Longitudinal Studies | 6 | 2024 | 14481 | 0.220 |
Why?
|
Tuberculoma | 1 | 2003 | 13 | 0.220 |
Why?
|
Aged | 24 | 2024 | 168217 | 0.220 |
Why?
|
Benzoxazoles | 1 | 2024 | 89 | 0.220 |
Why?
|
Blood Glucose | 2 | 2017 | 6347 | 0.220 |
Why?
|
Tuberculosis, Central Nervous System | 1 | 2003 | 16 | 0.220 |
Why?
|
Hypertension | 3 | 2020 | 8503 | 0.210 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2022 | 105 | 0.200 |
Why?
|
Societies, Scientific | 2 | 2020 | 220 | 0.200 |
Why?
|
Neuromuscular Diseases | 1 | 2004 | 255 | 0.190 |
Why?
|
Fludrocortisone | 1 | 2021 | 24 | 0.190 |
Why?
|
Wound Healing | 1 | 2013 | 2783 | 0.190 |
Why?
|
Prealbumin | 2 | 2024 | 222 | 0.190 |
Why?
|
Antiparkinson Agents | 2 | 2017 | 183 | 0.190 |
Why?
|
Fatigue Syndrome, Chronic | 2 | 2020 | 215 | 0.190 |
Why?
|
Syncope, Vasovagal | 2 | 2011 | 38 | 0.190 |
Why?
|
Receptors, Cholinergic | 3 | 2012 | 241 | 0.180 |
Why?
|
Pupil Disorders | 2 | 2012 | 32 | 0.180 |
Why?
|
Nerve Fibers, Unmyelinated | 1 | 2020 | 97 | 0.180 |
Why?
|
Single-Blind Method | 1 | 2024 | 1570 | 0.180 |
Why?
|
Consensus Development Conferences as Topic | 1 | 2020 | 168 | 0.170 |
Why?
|
Electrodiagnosis | 1 | 2020 | 148 | 0.170 |
Why?
|
Endovascular Procedures | 1 | 2013 | 2139 | 0.170 |
Why?
|
Analysis of Variance | 4 | 2013 | 6233 | 0.160 |
Why?
|
Disease Progression | 5 | 2024 | 13468 | 0.160 |
Why?
|
Societies, Medical | 5 | 2023 | 3891 | 0.160 |
Why?
|
Immunosuppressive Agents | 2 | 2009 | 4158 | 0.150 |
Why?
|
Complex Regional Pain Syndromes | 1 | 2019 | 121 | 0.150 |
Why?
|
Young Adult | 11 | 2021 | 58808 | 0.150 |
Why?
|
Follow-Up Studies | 5 | 2017 | 39060 | 0.150 |
Why?
|
Systole | 1 | 2020 | 936 | 0.150 |
Why?
|
Physical Examination | 2 | 2014 | 1244 | 0.150 |
Why?
|
Papillomavirus Infections | 2 | 2019 | 1612 | 0.150 |
Why?
|
Amyloid | 1 | 2022 | 841 | 0.140 |
Why?
|
Capillaries | 1 | 2020 | 744 | 0.140 |
Why?
|
Celiac Disease | 1 | 2005 | 822 | 0.140 |
Why?
|
Dyspnea | 1 | 2005 | 1344 | 0.140 |
Why?
|
Asymptomatic Diseases | 1 | 2020 | 584 | 0.140 |
Why?
|
Retinal Diseases | 1 | 2023 | 702 | 0.140 |
Why?
|
Hospitals, Special | 1 | 2017 | 91 | 0.140 |
Why?
|
Nervous System Diseases | 2 | 2020 | 1647 | 0.140 |
Why?
|
Supine Position | 1 | 2017 | 205 | 0.130 |
Why?
|
Paresthesia | 2 | 2008 | 162 | 0.130 |
Why?
|
Aged, 80 and over | 7 | 2024 | 58681 | 0.130 |
Why?
|
Reproducibility of Results | 5 | 2024 | 20052 | 0.130 |
Why?
|
Paraffin Embedding | 1 | 2017 | 302 | 0.130 |
Why?
|
Enteric Nervous System | 1 | 2019 | 212 | 0.130 |
Why?
|
Cross-Sectional Studies | 4 | 2024 | 25953 | 0.130 |
Why?
|
Cell Count | 2 | 2010 | 1835 | 0.130 |
Why?
|
Muscle, Smooth | 1 | 2019 | 924 | 0.130 |
Why?
|
Shy-Drager Syndrome | 2 | 2019 | 9 | 0.130 |
Why?
|
Brain | 3 | 2022 | 26951 | 0.130 |
Why?
|
Pain Measurement | 3 | 2020 | 3527 | 0.120 |
Why?
|
Reference Standards | 3 | 2023 | 1003 | 0.120 |
Why?
|
Headache | 1 | 2003 | 1248 | 0.120 |
Why?
|
Standard of Care | 3 | 2023 | 550 | 0.120 |
Why?
|
Nerve Fibers, Myelinated | 1 | 2020 | 952 | 0.120 |
Why?
|
Double-Blind Method | 2 | 2022 | 12262 | 0.120 |
Why?
|
Prospective Studies | 7 | 2024 | 54136 | 0.120 |
Why?
|
Conditioning, Operant | 1 | 1996 | 308 | 0.120 |
Why?
|
Severity of Illness Index | 4 | 2021 | 15785 | 0.120 |
Why?
|
Practice Guidelines as Topic | 3 | 2020 | 7377 | 0.120 |
Why?
|
Microscopy, Confocal | 1 | 2020 | 1969 | 0.110 |
Why?
|
Peripheral Vascular Diseases | 1 | 2017 | 488 | 0.110 |
Why?
|
Papillomaviridae | 1 | 2019 | 1121 | 0.110 |
Why?
|
Time Factors | 6 | 2016 | 39873 | 0.110 |
Why?
|
Piloerection | 1 | 2012 | 5 | 0.110 |
Why?
|
Reference Values | 3 | 2015 | 4919 | 0.110 |
Why?
|
Clinical Protocols | 1 | 2019 | 1436 | 0.110 |
Why?
|
Microscopy, Fluorescence | 1 | 2020 | 2646 | 0.110 |
Why?
|
Predictive Value of Tests | 5 | 2020 | 15225 | 0.100 |
Why?
|
Iontophoresis | 2 | 2012 | 74 | 0.100 |
Why?
|
Laryngeal Neoplasms | 1 | 2016 | 514 | 0.100 |
Why?
|
Axons | 2 | 2012 | 1674 | 0.100 |
Why?
|
Reflex, Pupillary | 1 | 2012 | 59 | 0.100 |
Why?
|
Case-Control Studies | 3 | 2020 | 22031 | 0.100 |
Why?
|
Silicones | 2 | 2012 | 227 | 0.100 |
Why?
|
Cohort Studies | 5 | 2024 | 41252 | 0.090 |
Why?
|
Pilot Projects | 2 | 2022 | 8554 | 0.090 |
Why?
|
Plasma Exchange | 1 | 2011 | 158 | 0.090 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2022 | 1842 | 0.090 |
Why?
|
Leg | 1 | 2015 | 1087 | 0.090 |
Why?
|
Diagnosis, Differential | 4 | 2020 | 12951 | 0.090 |
Why?
|
Antihypertensive Agents | 1 | 2020 | 2018 | 0.090 |
Why?
|
Electrophysiology | 1 | 2013 | 1263 | 0.090 |
Why?
|
Retrospective Studies | 7 | 2021 | 80170 | 0.090 |
Why?
|
Consensus | 1 | 2020 | 3099 | 0.090 |
Why?
|
Ion Channels | 1 | 2014 | 1043 | 0.080 |
Why?
|
Ubiquitin Thiolesterase | 2 | 2011 | 454 | 0.080 |
Why?
|
Antibodies | 3 | 2012 | 2420 | 0.080 |
Why?
|
Wallerian Degeneration | 1 | 2009 | 68 | 0.080 |
Why?
|
Reward | 1 | 1996 | 965 | 0.080 |
Why?
|
Hypohidrosis | 1 | 2009 | 29 | 0.080 |
Why?
|
Sensation | 1 | 2010 | 331 | 0.080 |
Why?
|
Lower Extremity | 1 | 2017 | 1188 | 0.080 |
Why?
|
Neurodegenerative Diseases | 1 | 2018 | 1081 | 0.080 |
Why?
|
Administration, Topical | 1 | 2010 | 697 | 0.080 |
Why?
|
Hyperhidrosis | 1 | 2008 | 34 | 0.080 |
Why?
|
Intestines | 1 | 1997 | 1906 | 0.080 |
Why?
|
Cytological Techniques | 1 | 2010 | 218 | 0.080 |
Why?
|
Androgens | 1 | 1996 | 1291 | 0.080 |
Why?
|
Diabetic Retinopathy | 1 | 2017 | 1267 | 0.070 |
Why?
|
Animals | 10 | 2022 | 167777 | 0.070 |
Why?
|
Boston | 2 | 2020 | 9304 | 0.070 |
Why?
|
Automation | 1 | 2010 | 581 | 0.070 |
Why?
|
Urination Disorders | 1 | 2009 | 240 | 0.070 |
Why?
|
Sjogren's Syndrome | 1 | 2009 | 235 | 0.070 |
Why?
|
Vasodilation | 1 | 2010 | 960 | 0.070 |
Why?
|
Acetylcholine | 1 | 2008 | 628 | 0.070 |
Why?
|
Vascular Diseases | 1 | 2014 | 1160 | 0.070 |
Why?
|
Cold Temperature | 1 | 2010 | 780 | 0.070 |
Why?
|
Forearm | 1 | 2008 | 427 | 0.060 |
Why?
|
Adrenergic Agonists | 1 | 2005 | 58 | 0.060 |
Why?
|
Attention | 2 | 2016 | 2387 | 0.060 |
Why?
|
Treatment Outcome | 5 | 2024 | 64379 | 0.060 |
Why?
|
Research Design | 1 | 2021 | 6154 | 0.060 |
Why?
|
Gliadin | 1 | 2005 | 80 | 0.060 |
Why?
|
Fatigue | 1 | 2012 | 1542 | 0.060 |
Why?
|
Combined Modality Therapy | 1 | 2017 | 8530 | 0.060 |
Why?
|
Adolescent | 4 | 2014 | 87888 | 0.060 |
Why?
|
Skin Temperature | 1 | 2004 | 96 | 0.060 |
Why?
|
Analgesics | 1 | 2011 | 1064 | 0.060 |
Why?
|
Models, Neurological | 1 | 2012 | 1757 | 0.060 |
Why?
|
Constipation | 1 | 2009 | 561 | 0.060 |
Why?
|
Reaction Time | 2 | 2012 | 2075 | 0.060 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2010 | 1111 | 0.050 |
Why?
|
Psychomotor Performance | 1 | 2011 | 1878 | 0.050 |
Why?
|
Neuropsychological Tests | 2 | 2016 | 7023 | 0.050 |
Why?
|
Sensory Thresholds | 1 | 2004 | 377 | 0.050 |
Why?
|
Adrenergic Agents | 1 | 2023 | 74 | 0.050 |
Why?
|
Tachycardia, Sinus | 1 | 2022 | 42 | 0.050 |
Why?
|
Clinical Laboratory Techniques | 1 | 2008 | 748 | 0.050 |
Why?
|
Registries | 1 | 2019 | 8176 | 0.050 |
Why?
|
Body Temperature Regulation | 1 | 2004 | 286 | 0.050 |
Why?
|
Cognition Disorders | 1 | 2016 | 3975 | 0.050 |
Why?
|
Blood Pressure Determination | 1 | 2006 | 634 | 0.050 |
Why?
|
Risk | 1 | 2014 | 9599 | 0.050 |
Why?
|
Nausea | 1 | 2005 | 677 | 0.050 |
Why?
|
Functional Laterality | 2 | 2012 | 2252 | 0.050 |
Why?
|
Pyridostigmine Bromide | 1 | 2021 | 30 | 0.050 |
Why?
|
Domperidone | 1 | 2021 | 24 | 0.050 |
Why?
|
Immunoglobulin A | 1 | 2005 | 979 | 0.050 |
Why?
|
Survival Rate | 1 | 2015 | 12721 | 0.050 |
Why?
|
Sensitivity and Specificity | 1 | 2016 | 14641 | 0.050 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2016 | 4023 | 0.050 |
Why?
|
HIV Infections | 2 | 2016 | 17275 | 0.050 |
Why?
|
Receptors, GABA | 1 | 2022 | 305 | 0.050 |
Why?
|
Dysautonomia, Familial | 1 | 2021 | 94 | 0.040 |
Why?
|
Age Factors | 1 | 2017 | 18357 | 0.040 |
Why?
|
Blood Vessels | 1 | 2005 | 1112 | 0.040 |
Why?
|
Fluorescent Antibody Technique | 2 | 2015 | 2470 | 0.040 |
Why?
|
Risk Factors | 2 | 2017 | 73806 | 0.040 |
Why?
|
Prevalence | 2 | 2006 | 15646 | 0.040 |
Why?
|
Data Interpretation, Statistical | 1 | 2008 | 2690 | 0.040 |
Why?
|
Peritoneal Cavity | 1 | 1997 | 138 | 0.040 |
Why?
|
Blood Volume | 1 | 2018 | 550 | 0.040 |
Why?
|
Cardiovascular System | 1 | 2004 | 835 | 0.030 |
Why?
|
Immunohistochemistry | 1 | 2010 | 11070 | 0.030 |
Why?
|
Linear Models | 1 | 2006 | 5861 | 0.030 |
Why?
|
Vasoconstriction | 1 | 2018 | 592 | 0.030 |
Why?
|
Immunoglobulin G | 1 | 2007 | 4540 | 0.030 |
Why?
|
Autoimmune Diseases | 1 | 2007 | 2244 | 0.030 |
Why?
|
Amphetamine | 1 | 1996 | 224 | 0.030 |
Why?
|
Immunity, Mucosal | 1 | 1997 | 481 | 0.030 |
Why?
|
Rabbits | 2 | 2011 | 4771 | 0.030 |
Why?
|
Neurology | 1 | 2020 | 778 | 0.030 |
Why?
|
Nitroprusside | 1 | 2012 | 272 | 0.030 |
Why?
|
Mice, SCID | 1 | 1997 | 2626 | 0.030 |
Why?
|
Phenylephrine | 1 | 2012 | 293 | 0.020 |
Why?
|
Equidae | 1 | 2011 | 10 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2016 | 2850 | 0.020 |
Why?
|
Phenotype | 1 | 2009 | 16534 | 0.020 |
Why?
|
H-Reflex | 1 | 2010 | 25 | 0.020 |
Why?
|
Vasoactive Intestinal Peptide | 1 | 2011 | 180 | 0.020 |
Why?
|
Age of Onset | 1 | 2017 | 3298 | 0.020 |
Why?
|
Tyrosine 3-Monooxygenase | 1 | 2011 | 370 | 0.020 |
Why?
|
Streptozocin | 1 | 2010 | 193 | 0.020 |
Why?
|
Lidocaine | 1 | 2012 | 537 | 0.020 |
Why?
|
Transplantation, Heterologous | 1 | 1997 | 2378 | 0.020 |
Why?
|
Vasoconstrictor Agents | 1 | 2012 | 651 | 0.020 |
Why?
|
Cross Reactions | 1 | 2011 | 818 | 0.020 |
Why?
|
Neural Conduction | 1 | 2010 | 441 | 0.020 |
Why?
|
Calcitonin Gene-Related Peptide | 1 | 2011 | 314 | 0.020 |
Why?
|
Patient Education as Topic | 1 | 2018 | 2307 | 0.020 |
Why?
|
Vasodilator Agents | 1 | 2012 | 973 | 0.020 |
Why?
|
Executive Function | 1 | 2016 | 1375 | 0.020 |
Why?
|
Prognosis | 2 | 2020 | 29558 | 0.020 |
Why?
|
Electric Stimulation | 1 | 2012 | 1732 | 0.020 |
Why?
|
Heart Ventricles | 1 | 2019 | 3806 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2013 | 2359 | 0.020 |
Why?
|
Rats | 2 | 2010 | 23681 | 0.020 |
Why?
|
Memory | 1 | 2016 | 2179 | 0.020 |
Why?
|
Respiration | 1 | 2013 | 1654 | 0.020 |
Why?
|
Intestinal Mucosa | 1 | 1997 | 3023 | 0.020 |
Why?
|
Species Specificity | 1 | 2011 | 2417 | 0.020 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2016 | 6013 | 0.020 |
Why?
|
United States | 3 | 2019 | 72140 | 0.020 |
Why?
|
Anesthetics, Local | 1 | 2012 | 1000 | 0.020 |
Why?
|
Tyrosine | 1 | 2010 | 1432 | 0.020 |
Why?
|
Patch-Clamp Techniques | 1 | 2007 | 931 | 0.010 |
Why?
|
Motor Neurons | 1 | 2010 | 864 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2021 | 10146 | 0.010 |
Why?
|
Membrane Potentials | 1 | 2007 | 1094 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2019 | 7985 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2019 | 6457 | 0.010 |
Why?
|
Models, Biological | 1 | 1997 | 9461 | 0.010 |
Why?
|
HIV-1 | 1 | 1997 | 6850 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 1997 | 10171 | 0.010 |
Why?
|
Cognition | 1 | 2017 | 6955 | 0.010 |
Why?
|
Image Enhancement | 1 | 2011 | 2880 | 0.010 |
Why?
|
Algorithms | 1 | 2018 | 13959 | 0.010 |
Why?
|
Mice | 2 | 2011 | 81107 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 2012 | 4902 | 0.010 |
Why?
|
Mutation | 1 | 2019 | 29915 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2010 | 18125 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2007 | 16886 | 0.010 |
Why?
|